Piroxicam Nanostructured Lipid Carrier Drug Delivery System

Abstract

Objective Nanostructured lipid carrier NLC based topical gel of Piroxicam PXM was formulated with the aim of controlled release action and to reduce systemic side effect for the treatment of an arthritic condition. Methods NLCs developed using high pressure homogenization method and optimized using a 32 factorial design with response surface methodology using design expert software. NLCs were characterized for particle size, zeta potential analysis, drug entrapment efficiency, and in vitro drug release studies to select the optimized formulation. The NLCs were suitably gelled and evaluated with respect to homogeneity, pH, viscosity, gel strength, spread ability, rheological characteristics, drug content, in vitro diffusion, and stability study. Safety of the NLC based gel was assessed using primary skin irritation studies, and efficacy was confirmed using carrageen an induced rat paw edema model. Results NLCs formulation comprising 2 of lipid 60 40 and surfactant 1.50 was confirmed as an optimized batch having a particle size 138.2±3.60 nm with polydispersibility index value 0.344±0.034. The zeta potential value indicates good physical stability. Based on the results from the in vitro release study it was shown that the formed gels had the ability to extend release of PXM for 24 h and showing percentage drug release of 90.92 ±1.96 at the end of 24 h. Skin irritation studies revealed that the optimized gel formulation shows no erythema, edema, or ulceration. Conclusion The overall results of the present study clearly indicated promising potentials of NLC based gel for delivering PXM topically over the conventional gel. Dr. G. Jagadish | Dr. Rita Mourya | Dr. Amith Nayak "Piroxicam Nanostructured Lipid Carrier Drug Delivery System" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-3 , April 2021, URL: https://www.ijtsrd.com/papers/ijtsrd39912.pdf Paper URL: https://www.ijtsrd.com/pharmacy/pharmaceutics/39912/piroxicam-nanostructured-lipid-carrier-drug-delivery-system/dr-g-jagadish

Authors and Affiliations

Dr. G. Jagadish | Dr. Rita Mourya | Dr. Amith Nayak

Keywords

Related Articles

Impact of Rice Husk Ash on Cement Concrete

Impact of rice husk fiery debris on cement concrete is a lab give an account of cement concrete is that the consuming of rice husks (RH) has made a high pozzolanic reactivity and property. Indian standard code of practic...

Occurrence and Distribution of Stork Species in Bundelkhand Region, the Drought Prone Landscape of India

Storks are large wading birds that are distributed across the Indian Sub Continent. They belong to the order Ciconiiformes, having long bills, necks and legs. The family Ciconiidae is closely associated with wetlands, ma...

A Complete Analysis of Corona Based Energy Efficient WSN Protocols

The main components of a wireless sensor network WSN are relay nodes, large number of sensor nodes, and a base station. The WSN is chiefly deployed to gather information from an environment. Due to its applicability, the...

Smart Blind Stick using Arduino

This paper describes ultrasonic blind walking stick with the use of arduino. According to WHO, Visually impaired can range from mild severe. Worldwide, between 300 million people are visually impaired due to various caus...

The Study of Coffee Shop: A Case Study of Taiwan

There are already many coffee houses in Taiwan, such as Taiwanese and independent coffee houses, and there is also a specialized coffee shop around the people of Taiwan. Taiwanese coffee houses occupy a significant share...

Download PDF file
  • EP ID EP695256
  • DOI -
  • Views 108
  • Downloads 0

How To Cite

Dr. G. Jagadish, Dr. Rita Mourya (2021). Piroxicam Nanostructured Lipid Carrier Drug Delivery System. International Journal of Trend in Scientific Research and Development, 5(3), -. https://www.europub.co.uk/articles/-A-695256